INKON Life Technology Co Ltd (300143) - Cash Flow Conversion Efficiency
Based on the latest financial reports, INKON Life Technology Co Ltd (300143) has a cash flow conversion efficiency ratio of 0.052x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥71.76 Million ≈ $10.50 Million USD) by net assets (CN¥1.38 Billion ≈ $201.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of INKON Life Technology Co Ltd to measure how much of total assets are equity-financed.
INKON Life Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how INKON Life Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check INKON Life Technology Co Ltd (300143) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
INKON Life Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of INKON Life Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Clevo Co
TW:2362
|
-0.065x |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
|
N/A |
|
Kura Oncology Inc
NASDAQ:KURA
|
-0.796x |
|
B-Soft Co Ltd
SHE:300451
|
-0.007x |
|
KRN Heat Exchanger and Refrigeration
NSE:KRN
|
0.107x |
|
Banco Mercantil do Brasil S.A
SA:BMEB3
|
-0.021x |
|
IRPC Public Company Limited
BK:IRPC-R
|
0.028x |
|
Malion New Materials Co Ltd
SHE:300586
|
0.008x |
Annual Cash Flow Conversion Efficiency for INKON Life Technology Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of INKON Life Technology Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see INKON Life Technology Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.62 Billion ≈ $382.85 Million |
CN¥340.83 Million ≈ $49.87 Million |
0.130x | +24.53% |
| 2024-12-31 | CN¥2.48 Billion ≈ $362.66 Million |
CN¥259.25 Million ≈ $37.94 Million |
0.105x | -21.34% |
| 2023-12-31 | CN¥1.43 Billion ≈ $209.08 Million |
CN¥190.01 Million ≈ $27.80 Million |
0.133x | +9.04% |
| 2022-12-31 | CN¥1.32 Billion ≈ $192.77 Million |
CN¥160.67 Million ≈ $23.51 Million |
0.122x | +75.31% |
| 2021-12-31 | CN¥1.81 Billion ≈ $264.20 Million |
CN¥125.61 Million ≈ $18.38 Million |
0.070x | +83.91% |
| 2020-12-31 | CN¥2.24 Billion ≈ $327.88 Million |
CN¥84.77 Million ≈ $12.40 Million |
0.038x | +73.71% |
| 2019-12-31 | CN¥1.37 Billion ≈ $200.10 Million |
CN¥29.78 Million ≈ $4.36 Million |
0.022x | -54.84% |
| 2018-12-31 | CN¥2.07 Billion ≈ $302.49 Million |
CN¥99.69 Million ≈ $14.59 Million |
0.048x | -29.68% |
| 2017-12-31 | CN¥2.43 Billion ≈ $355.97 Million |
CN¥166.82 Million ≈ $24.41 Million |
0.069x | +237.48% |
| 2016-12-31 | CN¥2.20 Billion ≈ $321.31 Million |
CN¥44.62 Million ≈ $6.53 Million |
0.020x | -42.42% |
| 2015-12-31 | CN¥1.48 Billion ≈ $217.17 Million |
CN¥52.37 Million ≈ $7.66 Million |
0.035x | -42.87% |
| 2014-12-31 | CN¥343.97 Million ≈ $50.33 Million |
CN¥21.25 Million ≈ $3.11 Million |
0.062x | +192.22% |
| 2013-12-31 | CN¥643.30 Million ≈ $94.14 Million |
CN¥13.60 Million ≈ $1.99 Million |
0.021x | -36.66% |
| 2012-12-31 | CN¥810.78 Million ≈ $118.64 Million |
CN¥27.06 Million ≈ $3.96 Million |
0.033x | -71.28% |
| 2011-12-31 | CN¥785.85 Million ≈ $114.99 Million |
CN¥91.32 Million ≈ $13.36 Million |
0.116x | +37.33% |
| 2010-12-31 | CN¥727.00 Million ≈ $106.38 Million |
CN¥61.51 Million ≈ $9.00 Million |
0.085x | -61.27% |
| 2009-12-31 | CN¥116.90 Million ≈ $17.11 Million |
CN¥25.54 Million ≈ $3.74 Million |
0.218x | -11.98% |
| 2008-12-31 | CN¥81.55 Million ≈ $11.93 Million |
CN¥20.24 Million ≈ $2.96 Million |
0.248x | -41.95% |
| 2007-12-31 | CN¥74.89 Million ≈ $10.96 Million |
CN¥32.02 Million ≈ $4.69 Million |
0.428x | -- |
About INKON Life Technology Co Ltd
INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was … Read more